Susan L Rossell Selected Research

Susan L Rossell Research Topics

34	Schizophrenia (Dementia Praecox) 12/2022 - 02/2006
27	Body Dysmorphic Disorders (Body Dysmorphic Disorder) 12/2021 - 01/2006
10	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 01/2022 - 01/2013
8	Psychotic Disorders (Schizoaffective Disorder) 03/2021 - 04/2015
5	Bipolar Disorder (Manic Depressive Psychosis) 02/2022 - 01/2020
5	Cognitive Dysfunction 12/2021 - 02/2006
3	Anorexia Nervosa 01/2022 - 11/2019
2	Wounds and Injuries (Trauma) 01/2021 - 01/2021
2	Neurobehavioral Manifestations 02/2020 - 08/2015
1	Substance-Related Disorders (Drug Abuse) 12/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Mental Disorders (Mental Disorder) 01/2021
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2021
1	Memory Disorders (Memory Loss) 10/2020
1	Alcoholism (Alcohol Abuse) 01/2020
1	Nausea 01/2020
1	Autism Spectrum Disorder 01/2020
1	Chronic Renal Insufficiency 10/2019
1	Sensorineural Hearing Loss 10/2018
1	Trichotillomania 01/2018
1	Treatment-Resistant Schizophrenia 03/2017
1	Cerebral Cortical Thinning 01/2017
1	Hallucinations (Hallucination) 01/2016
1	Stroke (Strokes) 01/2016
1	Mania (Manias) 06/2014

24	7,7'- dimethoxy- (4,4'- bi- 1,3- benzodioxole)- 5,5'- dicarboxylic acid dimethyl ester (BDD)IBA 12/2021 - 08/2010
12	Silver Sulfadiazine (SSD)FDA LinkGeneric 12/2022 - 01/2019
5	Acetylcysteine (Siran)FDA LinkGeneric 01/2022 - 12/2015
5	Biological ProductsIBA 01/2022 - 01/2017
4	Ketamine FDA LinkGeneric 04/2015 - 02/2006
3	Clozapine (Clozaril)FDA LinkGeneric 01/2022 - 12/2015
3	Methamphetamine (Desoxyn)FDA LinkGeneric 12/2021 - 01/2019
3	Pharmaceutical PreparationsIBA 01/2020 - 08/2014
3	Antipsychotic Agents (Antipsychotics)IBA 03/2017 - 01/2014
2	Glutathione (Reduced Glutathione)IBA 01/2022 - 02/2020
2	AntioxidantsIBA 01/2022 - 02/2020
2	ElementsIBA 01/2022 - 01/2018
2	Indicators and Reagents (Reagents)IBA 12/2021 - 06/2014
2	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 01/2019 - 10/2018
2	Muscarinic M1 ReceptorIBA 01/2019 - 10/2018
2	Cholinergic Agents (Cholinergics)IBA 10/2018 - 08/2015
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 04/2015 - 04/2009
1	Cysteine (L-Cysteine)FDA Link 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	norclozapineIBA 01/2022
1	Polytetrafluoroethylene (Teflon)FDA Link 03/2021
1	Triglycerides (Triacylglycerol)IBA 01/2021
1	Varenicline (Chantix)FDA Link 01/2020
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2020
1	Oxytocin (Pitocin)FDA LinkGeneric 01/2019
1	Dopamine Agonists (Dopamine Agonist)IBA 04/2015
1	antineoplaston A10 (A 10)IBA 12/2013
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2006

8	Therapeutics 01/2021 - 01/2016
1	Contraindications 12/2021
1	Transcranial Direct Current Stimulation 11/2019
1	Hearing Aids (Hearing Aid) 10/2018